Mavrilimumab Human Monoclonal Antibody
Mavrilimumabis a research-grade recombinant antibody targeting CD116. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
CD116, CSF2R, GMR-alpha, CSF2RA, Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, CSF2RY, GMCSFR-alpha, GM-CSF-R-alpha, CDw116
UniProt
P15509
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG4-lambda2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal D-Dimer Antibody (DD1) [DyLight 680]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
Mouse Monoclonal D-Dimer Antibody (DD1) [DyLight 680]
